Deliver to GERMANY
IFor best experience Get the App
Similac Infant Plus Stage 3 Follow-Up Formula Powder from 12 to 18 Months 400G Tin with Hmo, Supports Baby's Immunity and Brain Development
Details
- BrandSimilac
- Size400 g (Pack of
- Item Weight400 Grams
- Item FormPowder
- Age Range (Description)Infant
- Diet TypeVegetarian
Description
🍼 Nourish their future, one scoop at a time!
- TRUSTED BRAND - Similac, a name synonymous with quality and care.
- DUAL IMMUNE BLEND - Fortified with nutrients to enhance your baby's immunity.
- POWER OF 5 NUTRIENTS - Includes essential growth nutrients for holistic development.
- NUTRIENT RICH FORMULA - Packed with HMO, DHA, and Lutein for optimal growth.
- BRAIN EYE DEVELOPMENT - Specially designed to support cognitive and visual skills.
Similac Infant Plus Stage 3 is a premium follow-up formula designed for infants aged 12 to 18 months. This 400g powder is enriched with a dual immune blend, including HMO and nucleotides, to support your baby's immunity while promoting brain and eye development with essential nutrients like DHA and Lutein.
Specifications
| Manufacturer | Abbott Manufacturing Singapore Pvt Ltd |
| Country of Origin | Singapore |
| Product Dimensions | 12 x 4 x 12 cm; 400 g |
| ASIN | B09STH3Z6P |
Reviews
M**H
Good
Perfect formula for my baby. I am happy that my daughter likes it
N**E
Good
My baby not facing any stomach issues.
N**A
,,,,,,,
Product acha h,but price bahut jayada increase ho gya h,pehle 760 tha or ab 955 ho gya he,,🙄🙄🙄
R**N
Maufacturing date is a bit old
The manufacturing date is a bit outdated. It has not expired but the ones that are found in local shops are of latest manufacturing dates.
A**
Product damaged
Product come with damage
P**.
products is good overall but prices increased too much in last 4 months
when my baby was born 6 months ago that time its price was 760, 2 months later it was 850 and now it is 955. last 4-5 monhts 200+ Rs has been increased.
J**K
excellent
awsome product
Common Questions
Trustpilot
1 month ago
2 weeks ago
Get the App
